-

KARL STORZ Announces New Sponsorship to Help Connect EMS Providers With Grant Application and Funding Resources for Research and Patient Care

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ Endoscopy-America, Inc. is sponsoring an innovative program to facilitate efforts by Emergency Medical Services (EMS) and similar prehospital services to locate and benefit from resources that can be used to prepare and submit applications for third-party grants and funding to support research and/or patient care. The principal goal of the program is to help these essential public safety organizations apply for independent grant funding necessary to offer patients state-of-the-art airway management solutions.

The Grant Assistance Program (GAP) from EMSGrantsHelp.com, made possible in part through the sponsorship of KARL STORZ, offers an array of services and tools to help customers more effectively address their needs in applying for available grant funding. Intended for those who lack sufficient budgets to procure advanced airway products and technologies, customers who use the program will benefit from enhanced access to grant application services and resources that can be used to increase opportunities for grant funding.

Current estimates indicate that more than $600 billion in grants from federal, state, and private resources are available each year to public safety organizations, as well as local governments. Many such organizations, however, lack adequate time, research resources, and staffing to tap into and develop effective funding from grant sources. The GAP solution offered by EMSGrantsHelp.com, made possible in part through the sponsorship of KARL STORZ, provides targeted resources and visibility into grants available in a particular area. Access to personalized grant consulting and assistance from grant experts is also provided along with access to grant-writing services. In addition, GAP customers can benefit from public relations support when announcing developments in grant funding.

For more detailed information about GAP and related solutions and programs, visit https://www.emsgrantshelp.com/ and https://www.emsgrantshelp.com/karl-storz-grant-assistance.

About KARL STORZ

KARL STORZ Endoscopy-America, Inc. is an innovative leader in endoscopic technology and imaging solutions across virtually all surgical specialties. Its integration solutions enhance collaboration to improve clinical efficiency and outcomes inside the hospital and other sites of care. The group is an affiliate of KARL STORZ SE & Co. KG, a family-owned company based in Tuttlingen, Germany, that designs, engineers, manufactures, and markets all its products with an emphasis on visionary design, precision craftsmanship, and clinical effectiveness. For more information, call 800-421-0837 or visit the company’s website at www.karlstorz.com.

Contacts

Susan Mancia
Marketing Communications
KARL STORZ Endoscopy-America, Inc.
(424) 218-8100

KARL STORZ Endoscopy-America, Inc.


Release Versions

Contacts

Susan Mancia
Marketing Communications
KARL STORZ Endoscopy-America, Inc.
(424) 218-8100

Social Media Profiles
More News From KARL STORZ Endoscopy-America, Inc.

ADDING MULTIMEDIA KARL STORZ Announces FDA Clearance for ENDOFLATOR + Insufflator and Smoke Evacuation System

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a global leader in minimally invasive surgical technology, is proud to announce it has received U.S. Food and Drug Administration (FDA) clearance for the ENDOFLATOR™ +. ENDOFLATOR + is the next-generation insufflator with integrated surgical smoke evacuation system designed to meet the evolving needs of modern operating rooms. Using carbon dioxide gas, an insufflator establishes and maintains a stable working cavity within the body during laparos...

KARL STORZ Unifies Canada, US, and Veterinary Organizations to Form North America Region Led by Sonal Matai

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ, a family-owned medical technology company headquartered in Tuttlingen, Germany, today announced the creation of a North America region that unifies its US, Canada, and Veterinary businesses under the leadership of Sonal Matai. Matai joined KARL STORZ in 2022 and was appointed to lead KARL STORZ United States in early 2024. As President of North America, Matai will now oversee key functions such as commercial operations, research and development,...

AventaMed, a KARL STORZ Company, Receives Expanded Indication for Solo+ Tympanostomy Tube Device (TTD)

EL SEGUNDO, Calif.--(BUSINESS WIRE)--KARL STORZ United States is proud to announce that the US Food and Drug Administration (FDA) has cleared an expanded indication for the AventaMed Solo+™ Tympanostomy Tube Device (TTD), allowing its use in pediatric patients aged 6 months and older. This expanded clearance builds on the previous 510(k) clearance, which was indicated for patients 6 to 24 months old. The Solo+ device represents a significant advancement in pediatric ENT care. It is intended to...
Back to Newsroom